Arkolith/Insider Trading/KRON/Form 4

Knobelman Deborah

President & Interim CEOKronos Bio, Inc. (KRON) · full profile →Form 4 · filed Jun 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2025Sell(S)25K$0.87$22K139K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-016003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML